Benzinga | Nov 9, 2021 06:07PM EST

AbCellera Biologics Q3 EPS $(0.08) Down From $(0.02) YoY, Sales $5.51M Down From $9.36M YoY

AbCellera Biologics (NASDAQ:ABCL) reported quarterly losses of $(0.08) per share. This is a 300 percent decrease over losses of $(0.02) per share from the same period last year. The company reported $5.51 million in sales this quarter. This is a 41.17 percent decrease over sales of $9.36 million the same period last year.